Insulin and estrogen receptor ligand influence the FGF-2 activities in MCF-7 breast cancer cells. 2003

Martine Garnier, and Claire Giamarchi, and Isabelle Delrieu, and Marie-Christine Rio, and Patrick Chinestra, and Francis Bayard, and Marc Poirot, and Jean-Charles Faye
Département Innovation Therapeutique et Oncology INSERM U 563, Institut C. Regaud, 20-24 rue du pont Saint Pierre, Toulouse Cedex 31052, France.

From the MCF-7 cell line we have developed, a human mammary cancer cell subline with the same karyotype as the mother strain and named MCF-7(SF), able to grow in serum-free chemically defined medium. This cell subline was firstly used to analyze the effect of basic fibroblast growth factor (FGF-2) in estrogen-receptor-positive human breast cancer cells. FGF-2 like estradiol is able to increase cell proliferation and pS2 expression but was also found to inhibit progesterone receptor (PR) expression. The anti-estrogen tamoxifen partly counteracts the effects of FGF-2 and to discriminate between its two main mediators (estrogen receptor vs. anti-estrogen binding site, AEBS) we compare the efficacies of pure anti-estrogen (ICI 182,780) and AEBS ligand (PBPE). It appears that pure anti-estrogen counteracts cell growth and pS2 effects of FGF-2 since AEBS ligand inhibits the cell growth but has no activity on pS2 expression. Secondly, adding insulin (10(-6)M) in the culture medium induces a strong increase in cell proliferation, which then elicits an inhibitory effect of FGF-2 and addition of anti-estrogens, are less efficient to further decrease growth, since the effects of FGF-2 and anti-estrogens on pS2 expression are conserved.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D011960 Receptors, Estrogen Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important. Estrogen Receptor,Estrogen Receptors,Estrogen Nuclear Receptor,Estrogen Receptor Type I,Estrogen Receptor Type II,Estrogen Receptors Type I,Estrogen Receptors Type II,Receptor, Estrogen Nuclear,Receptors, Estrogen, Type I,Receptors, Estrogen, Type II,Nuclear Receptor, Estrogen,Receptor, Estrogen
D011980 Receptors, Progesterone Specific proteins found in or on cells of progesterone target tissues that specifically combine with progesterone. The cytosol progesterone-receptor complex then associates with the nucleic acids to initiate protein synthesis. There are two kinds of progesterone receptors, A and B. Both are induced by estrogen and have short half-lives. Progesterone Receptors,Progestin Receptor,Progestin Receptors,Receptor, Progesterone,Receptors, Progestin,Progesterone Receptor,Receptor, Progestin
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D004965 Estrogen Antagonists Compounds which inhibit or antagonize the action or biosynthesis of estrogenic compounds. Estradiol Antagonists,Antagonists, Estradiol,Antagonists, Estrogen
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000071163 Trefoil Factor-1 A 60 amino acid (6.5 kDa) trefoil factor that contains a single trefoil domain. It is expressed primarily by surface EPITHELIAL CELLS of the GASTRIC MUCOSA, where it associates with MUCIN 5AC. Protein pS2,TFF1 Peptide,TFF1 Protein,Trefoil Peptide 1,Trefoil Factor 1,pS2, Protein

Related Publications

Martine Garnier, and Claire Giamarchi, and Isabelle Delrieu, and Marie-Christine Rio, and Patrick Chinestra, and Francis Bayard, and Marc Poirot, and Jean-Charles Faye
July 2012, BMC cancer,
Martine Garnier, and Claire Giamarchi, and Isabelle Delrieu, and Marie-Christine Rio, and Patrick Chinestra, and Francis Bayard, and Marc Poirot, and Jean-Charles Faye
October 1993, International journal of oncology,
Martine Garnier, and Claire Giamarchi, and Isabelle Delrieu, and Marie-Christine Rio, and Patrick Chinestra, and Francis Bayard, and Marc Poirot, and Jean-Charles Faye
December 2016, Phytotherapy research : PTR,
Martine Garnier, and Claire Giamarchi, and Isabelle Delrieu, and Marie-Christine Rio, and Patrick Chinestra, and Francis Bayard, and Marc Poirot, and Jean-Charles Faye
December 2013, Journal of cancer research and clinical oncology,
Martine Garnier, and Claire Giamarchi, and Isabelle Delrieu, and Marie-Christine Rio, and Patrick Chinestra, and Francis Bayard, and Marc Poirot, and Jean-Charles Faye
June 1998, Molecular and cellular endocrinology,
Martine Garnier, and Claire Giamarchi, and Isabelle Delrieu, and Marie-Christine Rio, and Patrick Chinestra, and Francis Bayard, and Marc Poirot, and Jean-Charles Faye
September 2006, Biological chemistry,
Martine Garnier, and Claire Giamarchi, and Isabelle Delrieu, and Marie-Christine Rio, and Patrick Chinestra, and Francis Bayard, and Marc Poirot, and Jean-Charles Faye
April 1981, The Journal of biological chemistry,
Martine Garnier, and Claire Giamarchi, and Isabelle Delrieu, and Marie-Christine Rio, and Patrick Chinestra, and Francis Bayard, and Marc Poirot, and Jean-Charles Faye
January 2014, Biochemical and biophysical research communications,
Martine Garnier, and Claire Giamarchi, and Isabelle Delrieu, and Marie-Christine Rio, and Patrick Chinestra, and Francis Bayard, and Marc Poirot, and Jean-Charles Faye
December 2003, Carcinogenesis,
Martine Garnier, and Claire Giamarchi, and Isabelle Delrieu, and Marie-Christine Rio, and Patrick Chinestra, and Francis Bayard, and Marc Poirot, and Jean-Charles Faye
November 1990, Molecular endocrinology (Baltimore, Md.),
Copied contents to your clipboard!